Audrey Muller

1.0k total citations
26 papers, 708 citations indexed

About

Audrey Muller is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Audrey Muller has authored 26 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Audrey Muller's work include Pulmonary Hypertension Research and Treatments (13 papers), Lysosomal Storage Disorders Research (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Audrey Muller is often cited by papers focused on Pulmonary Hypertension Research and Treatments (13 papers), Lysosomal Storage Disorders Research (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Audrey Muller collaborates with scholars based in Switzerland, Spain and United Kingdom. Audrey Muller's co-authors include Amélie Beaudet, Marc C. Patterson, Charlotte Hyldgaard, Ole Hilberg, Elisabeth Bendstrup, Barbara Schwierin, Eugen Mengel, Marie T. Vanier, Mercè Pineda and Frits A. Wijburg and has published in prestigious journals such as Human Molecular Genetics, Archives of Disease in Childhood and BMJ Open.

In The Last Decade

Audrey Muller

25 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Audrey Muller Switzerland 10 372 296 123 112 107 26 708
Leyla Tümer Türkiye 15 175 0.5× 56 0.2× 24 0.2× 82 0.7× 44 0.4× 84 663
S. Waldek United Kingdom 10 377 1.0× 150 0.5× 49 0.4× 154 1.4× 76 0.7× 18 625
Frédéric Barbey Switzerland 16 671 1.8× 231 0.8× 43 0.3× 321 2.9× 160 1.5× 44 1.1k
B. Schlüter Germany 13 120 0.3× 76 0.3× 29 0.2× 42 0.4× 21 0.2× 46 471
Luciano Corda Italy 19 351 0.9× 414 1.4× 96 0.8× 26 0.2× 8 0.1× 63 841
Hiromitsu Takakura Japan 10 115 0.3× 66 0.2× 90 0.7× 112 1.0× 15 0.1× 46 341
Michel Tchan Australia 19 478 1.3× 41 0.1× 216 1.8× 248 2.2× 39 0.4× 76 1.1k
M. Nissilä Finland 18 94 0.3× 33 0.1× 21 0.2× 73 0.7× 12 0.1× 50 899
J Calvin United Kingdom 11 118 0.3× 47 0.2× 17 0.1× 57 0.5× 17 0.2× 23 426
K. Stewart Canada 13 105 0.3× 158 0.5× 106 0.9× 25 0.2× 3 0.0× 21 562

Countries citing papers authored by Audrey Muller

Since Specialization
Citations

This map shows the geographic impact of Audrey Muller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Muller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Muller more than expected).

Fields of papers citing papers by Audrey Muller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Muller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Muller. The network helps show where Audrey Muller may publish in the future.

Co-authorship network of co-authors of Audrey Muller

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Muller. A scholar is included among the top collaborators of Audrey Muller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Muller. Audrey Muller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Söderberg, Stefan, et al.. (2024). Survival in Pulmonary Arterial Hypertension (PAH) for 669 Patients Treated with Selexipag in Clinical Practice: Insights from EXPOSURE. The Journal of Heart and Lung Transplantation. 43(4). S85–S85. 1 indexed citations
2.
Gaine, Seán, Pilar Escribano Subías, Audrey Muller, et al.. (2024). Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH‐CTD): Real‐world experience from EXPOSURE. Pulmonary Circulation. 14(3). e12403–e12403. 3 indexed citations
3.
Kiely, David G., Neil Hamilton, Fernando G. Exposto, et al.. (2024). Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service. BMJ Open. 14(1). e080068–e080068. 3 indexed citations
4.
Muller, Audrey, Pilar Escribano Subías, Catarina Fernandes, et al.. (2024). Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE. Advances in Therapy. 41(3). 1103–1119. 6 indexed citations
5.
Subías, Pilar Escribano, et al.. (2024). Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study). Advances in Therapy. 41(9). 3645–3663. 1 indexed citations
6.
Lawrie, Allan, Neil Hamilton, Steven L. Wood, et al.. (2024). Association of risk assessment at diagnosis with healthcare resource utilization and health‐related quality of life outcomes in pulmonary arterial hypertension. Pulmonary Circulation. 14(3). e12399–e12399. 1 indexed citations
7.
8.
Lawrie, Allan, Neil Hamilton, Steven L. Wood, et al.. (2022). Healthcare resource utilization and quality of life in patients with sarcoidosis‐associated pulmonary hypertension. Pulmonary Circulation. 12(4). e12136–e12136. 3 indexed citations
9.
Subías, Pilar Escribano, Patricia Biedermann, Audrey Muller, et al.. (2020). Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study. A2910–A2910. 1 indexed citations
10.
Jansa, Pavel, David Ambrož, Vladimír Dytrych, et al.. (2020). Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic. 1543–1543. 1 indexed citations
11.
12.
13.
Muller, Audrey, Stefan Söderberg, Pilar Escribano Subías, et al.. (2019). PDG37 REAL-WORLD USE OF SELEXIPAG AND OTHER PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPIES: AN OBSERVATIONAL COHORT STUDY IN PATIENTS WITH PAH (EXPOSURE). Value in Health. 22. S602–S603.
14.
Patterson, Marc C., Eugen Mengel, Marie T. Vanier, et al.. (2015). Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study. Orphanet Journal of Rare Diseases. 10(1). 65–65. 69 indexed citations
15.
Brand, Monika, Audrey Muller, Jonathan Alsop, et al.. (2015). Results from a 9‐year Intensive Safety Surveillance Scheme (IS3) in miglustat (Zavesca®)‐treated patients. Pharmacoepidemiology and Drug Safety. 24(3). 329–333. 12 indexed citations
16.
Patterson, Marc C., Eugen Mengel, Frits A. Wijburg, et al.. (2014). Longitudinal data from the international registry for Niemann-Pick disease type C (NPC). Molecular Genetics and Metabolism. 111(2). S85–S85. 1 indexed citations
17.
Patterson, Marc C., Eugen Mengel, Frits A. Wijburg, et al.. (2013). Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet Journal of Rare Diseases. 8(1). 12–12. 145 indexed citations
18.
Hyldgaard, Charlotte, Ole Hilberg, Audrey Muller, & Elisabeth Bendstrup. (2013). A cohort study of interstitial lung diseases in central Denmark. Respiratory Medicine. 108(5). 793–799. 122 indexed citations
19.
Kuter, David J., Atul Mehta, Carla E. M. Hollak, et al.. (2013). Miglustat therapy in type 1 Gaucher disease: Clinical and safety outcomes in a multicenter retrospective cohort study. Blood Cells Molecules and Diseases. 51(2). 116–124. 49 indexed citations
20.
Bauer, Peter, David J. Balding, Hans H. Klünemann, et al.. (2013). Genetic screening for Niemann-Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study. Human Molecular Genetics. 22(21). 4349–4356. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leyla Tümer Breakdown of academic impact, for papers by S. Waldek Breakdown of academic impact, for papers by Frédéric Barbey Breakdown of academic impact, for papers by B. Schlüter Breakdown of academic impact, for papers by Luciano Corda Breakdown of academic impact, for papers by Hiromitsu Takakura Breakdown of academic impact, for papers by Michel Tchan Breakdown of academic impact, for papers by M. Nissilä Breakdown of academic impact, for papers by J Calvin Breakdown of academic impact, for papers by K. Stewart
Rankless by CCL
2026